QTMeds

Drug Database Monograph

XELJANZ 10 mg

PENDING REVIEW

Active Ingredient: TOFACITINIB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 61342424

← Back to Prescription Analyzer